Literature DB >> 19152969

High-titer IgE antibody specific for pollen allergens in northern California is associated with both wheezing and total serum IgE.

Elizabeth A Erwin, Jake Hosen, Susan M Pollart, Michael J Reid, Thomas A E Platts-Mills.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19152969      PMCID： PMC2699756          DOI： 10.1016/j.jaci.2008.11.042

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  10 in total

1.  Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions.

Authors:  H Wan; H L Winton; C Soeller; E R Tovey; D C Gruenert; P J Thompson; G A Stewart; G W Taylor; D R Garrod; M B Cannell; C Robinson
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

2.  Immunoglobulin E antibodies to pollen allergens account for high percentages of total immunoglobulin E protein.

Authors:  G J Gleich; G L Jacob
Journal:  Science       Date:  1975-12-12       Impact factor: 47.728

3.  The role of indoor allergens in chronic allergic disease.

Authors:  Thomas A E Platts-Mills
Journal:  J Allergy Clin Immunol       Date:  2007-02       Impact factor: 10.793

4.  Contribution of dust mite and cat specific IgE to total IgE: relevance to asthma prevalence.

Authors:  Elizabeth A Erwin; Eva Rönmark; Kristin Wickens; Matthew S Perzanowski; David Barry; Bo Lundbäck; Julian Crane; Thomas A E Platts-Mills
Journal:  J Allergy Clin Immunol       Date:  2007-02       Impact factor: 10.793

5.  Association of asthma with serum IgE levels and skin-test reactivity to allergens.

Authors:  B Burrows; F D Martinez; M Halonen; R A Barbee; M G Cline
Journal:  N Engl J Med       Date:  1989-02-02       Impact factor: 91.245

6.  Grass group I allergens (beta-expansins) are novel, papain-related proteinases.

Authors:  K Grobe; W M Becker; M Schlaak; A Petersen
Journal:  Eur J Biochem       Date:  1999-07

7.  Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study.

Authors:  T Platts-Mills; J Vaughan; S Squillace; J Woodfolk; R Sporik
Journal:  Lancet       Date:  2001-03-10       Impact factor: 79.321

8.  Cat and dust mite sensitivity and tolerance in relation to wheezing among children raised with high exposure to both allergens.

Authors:  Elizabeth A Erwin; Kristin Wickens; Natalie J Custis; Robert Siebers; Judith Woodfolk; David Barry; Julian Crane; Thomas A E Platts-Mills
Journal:  J Allergy Clin Immunol       Date:  2005-01       Impact factor: 10.793

9.  Epidemiology of emergency room asthma in northern California: association with IgE antibody to ryegrass pollen.

Authors:  S M Pollart; M J Reid; J A Fling; M D Chapman; T A Platts-Mills
Journal:  J Allergy Clin Immunol       Date:  1988-08       Impact factor: 10.793

10.  Sensitization and exposure to indoor allergens as risk factors for asthma among patients presenting to hospital.

Authors:  L E Gelber; L H Seltzer; J K Bouzoukis; S M Pollart; M D Chapman; T A Platts-Mills
Journal:  Am Rev Respir Dis       Date:  1993-03
  10 in total
  2 in total

1.  Galactose-α-1,3-galactose-specific IgE is associated with anaphylaxis but not asthma.

Authors:  Scott P Commins; Libby A Kelly; Eva Rönmark; Hayley R James; Shawna L Pochan; Edward J Peters; Bo Lundbäck; Lucy W Nganga; Philip J Cooper; Janelle M Hoskins; Saju S Eapen; Luis A Matos; Dane C McBride; Peter W Heymann; Judith A Woodfolk; Matthew S Perzanowski; Thomas A E Platts-Mills
Journal:  Am J Respir Crit Care Med       Date:  2012-01-26       Impact factor: 21.405

2.  The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-α-1,3-galactose.

Authors:  Scott P Commins; Hayley R James; Libby A Kelly; Shawna L Pochan; Lisa J Workman; Matthew S Perzanowski; Katherine M Kocan; John V Fahy; Lucy W Nganga; Eva Ronmark; Philip J Cooper; Thomas A E Platts-Mills
Journal:  J Allergy Clin Immunol       Date:  2011-03-31       Impact factor: 10.793
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.